ArticleDiabetes & metabolic syndrome
Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India.
Article in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 69 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 4 syntheses or guidelines pooled it, 155 citations in OpenAlex.
- Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis.Scientific reports · 2022Pooled it
- Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis.Journal of medical virology · 2022Pooled it
- Inactivated vaccine Covaxin/BBV152: A systematic review.Frontiers in immunology · 2022Pooled it
- Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.Travel medicine and infectious diseasePooled it
- Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population.Journal of family medicine and primary care · 2025Article
- Revealing COVID-19 breakthrough infection rates among vaccinated individuals at a tertiary care centre in South India.Iranian journal of microbiology · 2025Article
- COVID-19 breakthrough infections in vaccinated individuals at BPKIHS, Nepal.BMC infectious diseases · 2024Article
- Article
- Clinical characterization, molecular and genomic sequencing analysis of SARS-Cov-2 during second wave at Raigarh, Chhattisgarh, India.Bioinformation · 2024Article
- COVID-19 infection after vaccination.Caspian journal of internal medicine · 2024Article
- Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study.BMC public health · 2023Article
- Fair-split distribution of multi-dose vaccines with prioritized age groups and dynamic demand: The case study of COVID-19.European journal of operational research · 2023Article
- Article
- Breakthrough infection among healthcare personnel following exposure to COVID-19: Experience after one year of the world's largest vaccination drive.Journal of family medicine and primary care · 2023Article
- A study to assess the severity and risk of COVID-19 breakthrough infection in admitted SARS-CoV-2 vaccinated individual.Journal of family medicine and primary care · 2023Article
- Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves.Journal of family medicine and primary care · 2023Article
- Impact of Health Workers' Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey.Vaccines · 2023Article
- Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19.Microbes and infection · 2023Article
- COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates.Journal of epidemiology and global health · 2023Article
- Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India.PLOS global public health · 2023Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsVaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility.
methodsWe reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date.
resultsOut of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease.
conclusionsWe report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.